PharmExec Blog
Follow Us
RSS
Bookstore
Category Archives: Advertising
Genentech Runs Voluntary Corrective Ads for Boniva
Even though Roche-owned Genentech wasn’t required to run costly corrective advertisements following an FDA Untitled Letter on Boniva last January, the company has done so anyway.
Also posted in Corporate Responsibility, FDA, Legal, Marketing, Regulatory, compliance, leadership Tagged DDMAC, Genentech, OPDP, Roche Leave a comment
Off-Label Comments Online: Keep Doing What You're Doing, Says FDA
Those in favor of a less is more approach to FDA social media guidelines got what they wanted for the holidays: a trim, 15-page document on how to respond to unsolicited off-label comments
Also posted in E-Media, FDA, Legal, Marketing, Regulatory, Technology, compliance, social media Tagged FDA Leave a comment
Why the Delay on Facts Boxes?
Despite a near-complete absence of criticism coming from industry, academia, clinicians and patients, the drug facts box – a concise, quantitative, easy-to-read format for presenting a drug’s risk/benefit profile in print advertisements – seems at least three years away from launch.
Also posted in FDA, Legal, Marketing, Regulatory, Strategy, patient education Tagged facts box 1 Comment
Pfizer CEO: DTC a 'Fundamental Right'
Direct-to-consumer (DTC) advertising is a “fundamental right in the U.S.,” and denying the right of industry to speak directly to patients through drug advertising “leads to ignorance and the inability to judge,” said Ian Read, Pfizer’s president and CEO, at the Cleveland Clinic on Tuesday.
Asked whether DTC ads on television should be retired, Read answered [...]
Also posted in IP, Marketing, Patient Communication, Regulatory, Strategy, leadership, patient education Tagged DTC, Pfizer CEO 7 Comments
Sales Rep vs. eDetail: Consider the Practice Area